Indian equity markets experienced a cautious close on Friday, with the BSE Sensex and NSE Nifty50 declining amidst concerns over rupee weakness and rising fuel prices. However, despite the broader market sentiment, several individual stocks are drawing attention from brokerage firms, which have issued 'Buy' recommendations for the upcoming trading sessions.
Specifically, Lupin, Samvardhana Motherson International Ltd, and Max Healthcare Institute Ltd are under the spotlight, with analysts citing strong technical indicators and potential for upside. Investors are advised to consider the detailed target prices and stop-loss levels provided by these experts.
Max Healthcare Institute: Conditional Buy Above Rs 1,060
According to SMC Global, Max Healthcare is nearing a critical technical inflection point. The stock's price action is consolidating within a long-term symmetrical triangle structure on the daily chart. It has consistently formed higher lows while encountering resistance near its falling trend line and the 200-DMA, signaling a gradual increase in buying momentum.
- Recommendation: Conditional Buy above Rs 1,060
- Target Price: Rs 1,175-1,180
- Stop Loss: Rs 990
Recent trading patterns suggest accumulation at lower levels, indicating that bulls are attempting to regain control after a prolonged corrective phase. Momentum indicators like RSI (above midline) and MACD (in recovery mode) also show a positive bias. A decisive breakout above the Rs 1,050–1,060 zone is expected to confirm a trend reversal, potentially triggering fresh upward momentum towards higher resistance levels.
Lupin: Buy with Upside Potential to Rs 2,490
SMIFS highlights that Lupin Ltd is approaching its crucial 100-DMA support zone, ranging from Rs 2,250 to Rs 2,200. This level has historically been a strong buying zone during previous corrections since November, with the stock consistently reversing upwards from this area, indicating sustained demand on dips.
- Recommendation: Buy
- Target Price: Rs 2,490
- Stop Loss: Rs 2,120
The recent 5 percent decline in Lupin's share price appears to be a panic-driven pullback within a broader uptrend, reinforced by the pharma sector's lifetime high breakout. This setup presents a favorable risk-reward opportunity. The stock's structure remains positive, with potential upside towards Rs 2,490, provided it holds above the Rs 2,120 level.
Samvardhana Motherson International: Conditional Buy Above Rs 133
SMC Global identifies a strong bullish structure for Samvardhana Motherson International on the daily chart. The stock is steadily moving towards a breakout from an ascending triangle pattern near the Rs 130–133 zone. The formation of higher lows reflects sustained buying interest and growing confidence among market participants following a sharp recovery from earlier lows.
- Recommendation: Conditional Buy above Rs 133
- Target Price: Rs 149-150
- Stop Loss: Rs 123
Motherson continues to trade above its rising support trend line and key moving averages, maintaining a positive broader trend. Supportive momentum indicators suggest a gradual build-up of strength. Repeated testing of the resistance area indicates that sellers are losing grip as buyers absorb supply. A sustained move above the Rs 133–135 zone could initiate fresh upside momentum and continue the ongoing uptrend.
Disclaimer: This information is for educational and informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.